188 related articles for article (PubMed ID: 17068012)
1. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas.
Narayana A; Chang J; Thakur S; Huang W; Karimi S; Hou B; Kowalski A; Perera G; Holodny A; Gutin PH
Br J Radiol; 2007 May; 80(953):347-54. PubMed ID: 17068012
[TBL] [Abstract][Full Text] [Related]
2. Image-fusion of MR spectroscopic images for treatment planning of gliomas.
Chang J; Thakur S; Perera G; Kowalski A; Huang W; Karimi S; Hunt M; Koutcher J; Fuks Z; Amols H; Narayana A
Med Phys; 2006 Jan; 33(1):32-40. PubMed ID: 16485406
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (fMRI) for radiotherapy treatment planning of glioma.
Chang J; Thakur SB; Huang W; Narayana A
Technol Cancer Res Treat; 2008 Oct; 7(5):349-62. PubMed ID: 18783284
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
5. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopy imaging in radiotherapy planning for recurrent glioma.
Ballangrud AM; Lymberis S; Thakur SB; Karimi S; Huang W; Abrey LE; Beal K; Iwamoto FM; Brennan C; Gutin PH; Chang J
Med Phys; 2011 May; 38(5):2724-30. PubMed ID: 21776809
[TBL] [Abstract][Full Text] [Related]
7. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
8. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O
Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
[TBL] [Abstract][Full Text] [Related]
10. [Proton magnetic resonance spectroscopic imaging and other types of metabolic imaging for radiotherapy planning in adult and pediatric high-grade gliomas].
Laprie A
Cancer Radiother; 2009 Oct; 13(6-7):556-61. PubMed ID: 19766525
[TBL] [Abstract][Full Text] [Related]
11. Integration of BOLD-fMRI and DTI into radiation treatment planning for high-grade gliomas located near the primary motor cortexes and corticospinal tracts.
Wang M; Ma H; Wang X; Guo Y; Xia X; Xia H; Guo Y; Huang X; He H; Jia X; Xie Y
Radiat Oncol; 2015 Mar; 10():64. PubMed ID: 25884395
[TBL] [Abstract][Full Text] [Related]
12. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
13. Feasibility study of intensity-modulated radiotherapy (IMRT) treatment planning using brain functional MRI.
Chang J; Kowalski A; Hou B; Narayana A
Med Dosim; 2008; 33(1):42-7. PubMed ID: 18262122
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
Dhermain F
Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for cerebral malignant gliomas.
Zheng R; Fan R; Wen H; Luo J; Yang Y
J BUON; 2015; 20(1):248-52. PubMed ID: 25778324
[TBL] [Abstract][Full Text] [Related]
16. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
17. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy.
Pirzkall A; Nelson SJ; McKnight TR; Takahashi MM; Li X; Graves EE; Verhey LJ; Wara WW; Larson DA; Sneed PK
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1254-64. PubMed ID: 12128127
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
19. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
[TBL] [Abstract][Full Text] [Related]
20. Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies.
Tsien C; Gomez-Hassan D; Ten Haken RK; Tatro D; Junck L; Chenevert TL; Lawrence T
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):328-32. PubMed ID: 15890571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]